As a key targeted drug for advanced renal cell carcinoma, the Laos Big Bear version of Axitinib provides a new treatment option for patients with metastatic renal cancer due to its highly selective VEGFR inhibition.
Does Axitinib have a generic version in Laos?
Yes, Axitinib has a generic version in Laos. The Laos Big Bear version of Axitinib is available in the specification of 5mg*30 tablets/box. For more questions, it is recommended that you contact professional customer service for detailed consultation.
Axitinib Indications and Therapeutic Positioning
Axitinib (Inlyta) is a targeted therapy drug primarily used for the treatment of advanced renal cell carcinoma (RCC) in adults. Its clear indication is: treatment of advanced RCC patients who have failed prior therapy with one tyrosine kinase inhibitor (TKI) or cytokine therapy. This means Axitinib is usually used as a second-line therapy, suitable for patients whose disease progressed or did not respond to first-line treatment. By inhibiting signaling pathways related to tumor angiogenesis, Axitinib can delay tumor growth and improve patient outcomes. Before use, physicians should confirm the patient's prior treatment history and tumor progression status to ensure the indication match. This defined patient population is based on multiple clinical study results, demonstrating clear therapeutic benefits of Axitinib in specific RCC patients.
Axitinib Dosage and Administration and Adjustment Principles
The recommended starting dose of Axitinib is 5 mg orally twice daily, approximately 12 hours apart, with or without food. The drug should be swallowed whole with a glass of water, and should not be crushed or split. Dose adjustments may be made based on individual safety and tolerability. If co-administration with strong CYP3A4/5 inhibitors is required, it is recommended to reduce the Axitinib dose by half; for patients with moderate hepatic impairment, the starting dose should also be reduced by half. Dose adjustments should be conducted under a physician's guidance, without self-modification. Additionally, if a dose is missed or vomiting occurs, do not take a make-up dose; instead, take the next scheduled dose on time. Standardized administration can improve efficacy and reduce the incidence of adverse reactions.
